138 / 146
AFROCENTRIC GROUP
134
GLOSSARY
“ACT”
AfroCentric Investment Corporation Limited
“AfroCentric” or “the Company”
AfroCentric Investment Corporation Limited – the Group holding company
“AGM”
Annual General Meeting
“AHA”
ACT Healthcare Assets Proprietary Limited
“AHL” or “AfroCentric Health”
AfroCentric Health Proprietary Limited
“AHS” or “AfroCentric Health Solutions”
AfroCentric Health Solutions Proprietary Limited
“B-BBEE”
Broad-based Black Economic Empowerment
“CEO”
Chief Executive Officer
“CFO”
Chief Financial Officer
“CIS”
Clinical Information System
“CMS”
Council of Medical Schemes
“COID”
Compensation for Occupational Injuries and Diseases
“CSI”
Corporate Social Investment
“DBC”
Documentation-based care
“ED”
Enterprise Development
“ERMF”
Enterprise Risk Management Framework
“ICT”
Information and Communications Technology
“IFM”
Insurance Fraud Manager from FICO
“IFRS”
International Financial Reporting Standards
“IIRC”
International Integrated Reporting Council
“JSE”
JSE Limited
“King III”
King Report of Corporate Governance of South Africa 2009
“LGRC”
Legal, Governance, Risk and Compliance
“MCC”
Medicines Control Council
“MD”
Managing Director
“MOI”
Memorandum of Incorporation which comprises the Company’s existing
memorandum of association and its articles of association
“NEHAWU”
National Education and Health Allied Workers Union
“NHI”
National Health Insurance
“SADC”
Southern African Development Community
“Sanlam”
Sanlam Life Insurance Limited
“SED”
Socio-economic development
“the Board”
The Board of Directors of AfroCentric Investment Corporation Limited
“the Companies Act”
The Companies Act 71 of 2008
“the current period”
The year ended 30 June 2017
“the current year”
The year ended 30 June 2017
“the Group”
AfroCentric Investment Corporation Limited, its subsidiaries and associates
“the previous year” or “the prior year”
The year ended 30 June 2016
“the year” or “the year under review”
The year ended 30 June 2017
“WAD Acquisition”
Pharmacy Direct Proprietary Limited, Curasana Wholesaler Proprietary Limited,
26% interest in Activo Health Proprietary Limited
“WAD”
WAD Holdings Proprietary Limited
SHAREHOLDER INFORMATION